1.
Lam C, Ferguson ID, Mariano MC, Lin Y-HT, Murnane M, Liu H, Smith GA, Wong SW, Taunton J, Liu JO, Mitsiades CS, Hann BC, Aftab BT, Wiita AP. Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica [Internet]. 2018Jul.3 [cited 2026Nov.6];103(7):1218-2. Available from: https://haematologica.org/article/view/8526